Advarra

We're dedicated to serving the clinical research community at Advarra, and that means staying on top of the latest trends. Our new eBook, "2023 Trends Impacting Clinical Research," is a valuable resource that can help you stay informed and adapt to the changes in the industry.

https://bit.ly/3RbN09J

Join us 1/26 for a webinar on the latest trends in regulatory and development challenges for rare/orphan diseases. Learn successful strategies for a proactive approach to gaining a rare/orphan disease designation and identify critical issues and steps to resolve them to achieve regulatory and development milestones. CE credits available. Register now!

https://info.advarra.com/trending-now-wbnr.html?utm_medium=social-media&utm_source=facebook&utm_campaign=trending-now-wbnr&utm_content=trending-now-wbnr

Trending Now: Regulatory and Development Challenges to Rare/Orphan Diseases Explore the latest trends in regulatory and development challenges for rare/orphan diseases.

If you’re not already using a single IRB (sIRB) for cooperative and multisite clinical trials, you probably will be soon. Relying on an sIRB can be challenging for institutions used to doing everything locally. Even those more familiar with sIRB reliance may still find it’s not as efficient or straightforward as promised. https://bit.ly/3CHFjlJ

How to Optimize Your sIRB Experience Find out how other institutions have used sIRB requirements as an opportunity to elevate their research programs.

An investigator-initiated trial (IIT) occurs when an investigator creates the idea for a study, develops the protocol, and serves as the sponsor and investigator for the trial. While this isn’t uncommon, careful planning is required in order for these trials to be successfully compliant.

Download our latest eBook: https://bit.ly/3EoEVdc

This case study outlines how a biopharmaceutical company partnered with Advarra to execute a phased approach to identify opportunities for improvement, analyze their current pharmacovigilance system state, and implement R&D industry best practices for regulatory compliance.

Developing an Enterprise Roadmap to Post-authorization Safety Studies Learn how an organization achieved organization-wide compliance and managed its post-authorization safety studies

Is your IRB prepared to review protocols involving mHealth and virtual trial apps?

What questions should you ask the sponsor or researcher about these technologies?

How can researchers at your institution better plan their protocols and documentation to aide IRB review?

IRB Review of Virtual Trial Technology Explore the current regulatory landscape governing mHealth and virtual trial applications.

Understanding the factors that influence the decision to participate in a study helps research professionals diagnose enrollment problems.

Infographic - Top Barriers to Participation in Clinical Trials Understanding the factors that influence the decision to participate in a study helps research professionals diagnose enrollment problems.

Research into participant experiences has consistently shown their desire to learn the results of research to which they’ve contributed. https://bit.ly/3NM9XwK

Return of Research Results to Study Participants Research into participant experiences has consistently shown their desire to learn the results of research to which they’ve contributed.

Curious about how AI is used in clinical research? Want to learn more about discriminatory AI?

Check out the latest episode of "Advarra in Conversations With…" to listen to Advarra IRB Chairperson Luke Gelinas and AI Ethics Advisor Reid Blackman Ph.D. discuss AI ethics and implications for clinical research. Don't miss out on this exciting and informative conversation!

Podcasts - Advarra The future of healthcare innovation hinges on research and clinical trials. The Advarra In Conversations With Podcast sits down with leading experts to dig into pressing issues and explore cornerstone solutions.

Regulatory agency guidance in the U.S. and EU strongly recommends keeping DSMBs completely independent from parties sponsoring, organizing, or conducting the clinical trial. Get the unblinded truth on what a DSMB does and how to set one up in this free white paper.

White Paper: Establishing and Operating a DSMB: Tips for Clinical Trial Success This white paper describes how to set up a data safety monitoring board and it's role in clinical research.

Institutional sites are critical to successful clinical research and the advancement of healthcare. That’s why at Advarra, everything we do is driven by site centricity. In this blog, learn how Advarra plays a role in the movement toward site centricity.

Advarra’s Support for Institutions - Advarra Find out how we keep site centricity at the forefront through our technology, services, and extraordinary team members.